Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Paresthesia 2Hypesthesia 2Depression 2Anxiety Disorders 2Surgical Wound Infection 1Hematologic Neoplasms 1Brain Neoplasms 1

Interventions

Therapeutics 4Psilocybin 3Surveys and Questionnaires 2Oxygen 2Methods 2Cognitive Behavioral Therapy 2enzalutamide 1darolutamide 1apalutamide 1abacavir 1Transurethral Resection of Prostate 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Thyroidectomy 1Standard of Care 1Saline Solution 1Psychotherapy 1Physical Examination 1Palliative Care 1Niacin 1Models, Nursing 1Mindfulness 1Methylphenidate 1Melatonin 1Injections 1Infliximab 1Hypnosis 1Ethanol 1Esketamine 1Early Detection of Cancer 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Depression × Oxygen × Clear all
NCT06799351 2025-02-12

OzoParQTmicrob

Dr. Negrin University Hospital

Phase 2/3 Recruiting
42 enrolled

Anxiety Disorders, Depression, Hypesthesia, Paresthesia

NCT06706544 2025-02-11

OzoParQT

Dr. Negrin University Hospital

Phase 2/3 Recruiting
42 enrolled

Anxiety Disorders, Depression, Hypesthesia, Paresthesia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡